Research Calls
- Upgrades:
- Con Edison (ED) upgraded to Neutral from Sell at Guggenheim; tgt $94
- CubeSmart (CUBE) upgraded to Strong Buy from Outperform at Raymond James; tgt lowered to $52
- DTE Energy (DTE) upgraded to Outperform from Neutral at Credit Suisse; tgt lowered to $140
- Motorola Solutions (MSI) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $240
- Saia (SAIA) upgraded to Buy from Neutral at UBS; tgt raised to $240
- TreeHouse Foods (THS) upgraded to Buy from Hold at Truist
- Trimble (TRMB) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt lowered to $67
- Zebra Tech (ZBRA) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt lowered to $335
- Downgrades:
- Autodesk (ADSK) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $225
- Axon (AXON) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $120
- Corning (GLW) downgraded to Neutral from Buy at Citigroup; tgt lowered to $37
- Covetrus (CVET) downgraded to Mkt Perform from Outperform at Raymond James
- Dow (DOW) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $78
- HP (HPQ) downgraded to Neutral from Buy at Citigroup; tgt lowered to $38
- JBG SMITH Properties (JBGS) downgraded to Peer Perform from Outperform at Wolfe Research; tgt lowered to $26
- LyondellBasell (LYB) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $115
- Pactiv Evergreen (PTVE) downgraded to Neutral from Buy at Citigroup; tgt lowered to $10
- Realty Income (O) downgraded to Peer Perform from Outperform at Wolfe Research; tgt $73
- Skillz (SKLZ) downgraded to Neutral from Buy at Citigroup; tgt lowered to $2.10
- WPP plc (WPP) downgraded to Underweight from Equal-Weight at Morgan Stanley
- Others:
- AbbVie (ABBV) initiated with an Underperform at SVB Leerink; tgt $140
- Alteryx (AYX) initiated with an Outperform at FBN Securities; tgt $80
- Amgen (AMGN) initiated with a Mkt Perform at SVB Leerink; tgt $256
- Century Therapeutics (IPSC) initiated with a Buy at H.C. Wainwright; tgt $27
- Compass Therapeutics (CMPX) assumed with a Buy at H.C. Wainwright; tgt $12
- Gilead Sciences (GILD) initiated with a Mkt Perform at SVB Leerink; tgt $68
- Hain Celestial (HAIN) initiated with an Outperform at Cowen; tgt $34
- Halozyme Therapeutics (HALO) initiated with an Outperform at SVB Leerink; tgt $52
- Horizon Pharma (HZNP) initiated with a Mkt Perform at SVB Leerink; tgt $95
- Johnson & Johnson (JNJ) assumed with an Outperform at SVB Leerink; tgt $200
- Lancaster Colony (LANC) initiated with a Market Perform at Cowen; tgt $140
- Ouster (OUST) initiated with an Overweight at Cantor Fitzgerald; tgt $8
- Pfizer (PFE) initiated with a Mkt Perform at SVB Leerink; tgt $55
- Porch Group (PRCH) initiated with an Overweight at JP Morgan; tgt $8
- Radius Health (RDUS) initiated with a Mkt Perform at SVB Leerink; tgt $7
- Regeneron Pharma (REGN) initiated with an Outperform at SVB Leerink; tgt $738
- Roivant Sciences (ROIV) initiated with an Outperform; tgt $6
- Sanofi (SNY) initiated with an Outperform at SVB Leerink
- Theravance Biopharma (TBPH) initiated with an Outperform at SVB Leerink; tgt $12
- Upwork (UPWK) initiated with a Sector Perform at RBC Capital Mkts; tgt $21
- Vertex Pharma (VRTX) initiated with a Mkt Perform at SVB Leerink; tgt $265
- Wabtec (WAB) initiated with an Overweight at Atlantic Equities; tgt $101